Some groups found that METTL1 is tumor-promoting in colon cancer, hepatocellular carcinoma, and head and neck squamous cell carcinoma [15–19]; additionally, opposite findings have also been reported [20, 21]. Here, METTL1 is linked to malignant colon neoplasm.